How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Tissue Cryo-embedding Machine Market
- By Product Type: Manual Cryo-embedding Machines, Semi-automatic Cryo-embedding Machines, Fully Automatic Cryo-embedding Machines
- By End User: Hospitals and Clinics, Research Laboratories, Pharmaceutical and Biotechnology Companies, Academic and Medical Institutions
- By Application: Histopathology, Immunohistochemistry, Molecular Biology, Clinical Diagnostics
- By Embedding Medium Compatibility: OCT Compound Compatible, Paraffin Compatible, Gelatin Compatible
- By Temperature Control Range: Standard Temperature Range (-20°C to -30°C), Extended Low Temperature Range (-30°C to -40°C)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Manual Cryo-embedding Machines leads By Product Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 284 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.171 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.179 →
Full report · locked preview
Everything inside the Tissue Cryo-embedding Machine Market report
A complete, evidence-based study - 12 chapters and 119 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Product Type 3
End User 4
Application 4
Embedding Medium Compatibility 3
Temperature Control Range 2
Companies profiled
Leica Biosystems
Thermo Fisher Scientific
Sakura Finetek
Milestone Medical
Histo-Line Laboratories
Bright Instrument Co. Ltd.
Matsunami Glass Ind. Ltd.
SLEE Medical GmbH
Microm International GmbH
Shandon (Thermo Fisher Scientific)
Leica Microsystems
Tissue-Tek (Sakura Finetek)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Leica Biosystems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Sakura Finetek
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Milestone Medical
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Histo-Line Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Bright Instrument Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Matsunami Glass Ind. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →SLEE Medical GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Microm International GmbH
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Shandon (Thermo Fisher Scientific)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Leica Microsystems
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Tissue-Tek (Sakura Finetek)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Olympus Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Zeiss
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Lab Vision Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$2,466M by 2033 · 9.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Manual Cryo-embedding Machines47.1
- Semi-automatic Cryo-embedding Machines31.8
- Fully Automatic Cryo-embedding Machines21.1
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$386.1M → $902.3M · 11.2%
Europe$269.1M → $557.3M · 9.5%
Asia Pacific$245.7M → $498.0M · 9.2%
Latin America$152.1M → $340.3M · 10.6%
Middle East and Africa$117.0M → $220.0M · 8.2%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →9.732026
9.732027
9.742028
9.762029
9.772030
9.782031
9.802032
9.802033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Leica Biosystems20.9
- Thermo Fisher Scientific17.9
- Sakura Finetek10.0
- Milestone Medical5.9
- Histo-Line Laboratories5.1
- Bright Instrument Co. Ltd.12.1
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Product Type15.3%
End User31.8%
Application25.7%
Embedding Medium Compatibility13.6%
Temperature Control Range13.6%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.8
- Europe22.1
- Asia Pacific19.8
- Latin America13.5
- Middle East and Africa8.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Leica Biosystems | 93 | 94 | 74 | 75 | 83 | 88 | 85 |
| Thermo Fisher Scientific | 71 | 72 | 83 | 68 | 85 | 80 | 77 |
| Sakura Finetek | 73 | 68 | 69 | 79 | 82 | 66 | 73 |
| Milestone Medical | 75 | 80 | 75 | 80 | 61 | 77 | 75 |
| Histo-Line Laboratories | 70 | 73 | 73 | 76 | 51 | 57 | 67 |
| Bright Instrument Co. Ltd. | 65 | 46 | 60 | 66 | 61 | 62 | 60 |
| Matsunami Glass Ind. Ltd. | 50 | 50 | 53 | 48 | 49 | 49 | 50 |
| SLEE Medical GmbH | 44 | 38 | 43 | 59 | 60 | 58 | 50 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Leica Biosystems
- Thermo Fisher Scientific
- Sakura Finetek
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Leica Biosystems | ◐ | ✓ | ✓ | − | ◐ | ✓ |
| Thermo Fisher Scientific | − | ◐ | ✓ | ◐ | ✓ | ✓ |
| Sakura Finetek | ◐ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Milestone Medical | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Histo-Line Laboratories | ◐ | ✓ | ◐ | ✓ | − | ◐ |
| Bright Instrument Co. Ltd. | ◐ | − | − | − | − | − |
| Matsunami Glass Ind. Ltd. | − | − | ◐ | ◐ | ◐ | − |
| SLEE Medical GmbH | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Leica Biosystems85
2Thermo Fisher Scientific77
3Milestone Medical75
4Sakura Finetek73
5Histo-Line Laboratories67
6Bright Instrument Co. Ltd.60
7Matsunami Glass Ind. Ltd.50
8SLEE Medical GmbH50
Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Leica Biosystems
Challenger4
Strong scale, closing on the leaders.
Thermo Fisher ScientificSakura FinetekMilestone MedicalHisto-Line Laboratories
Contender1
Focused players with pockets of strength.
Bright Instrument Co. Ltd.
Niche2
Specialists in a single segment or region.
Matsunami Glass Ind. Ltd.SLEE Medical GmbH
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Product Type in North America, then scale across Tissue Cryo-embedding Machine Market — a $592M beachhead inside a $8.77B market.
Beachhead (SOM)$592Mobtainable near-term
Serviceable (SAM)$3.52Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Manual Cryo-embedding Machines
Best fit — highest urgency & budget in Product Type.
Economic buyer77 fit
Semi-automatic Cryo-embedding Machines
Strong fit — clear ROI and a fast path to value.
End user68 fit
Fully Automatic Cryo-embedding Machines
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Product Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel29%
Digital / self-serve22%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Product Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Tissue Cryo-embedding Machine Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified24%
Evaluation13%
Closed-won7%
$22.0KCAC
$119KLTV
5.4:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Tissue Cryo-embedding Machine Market is a high-growth opportunity — $5.92B by 2033, compounding at 10.5%.
TAM · 2025$2.66Btoday
TAM · 2033$5.92Bforecast
CAGR10.5%2027–2033
Cumulative$36.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.92BTotal addressable market
SAM$2.09BServiceable available market
SOM$413MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →10.5% CAGR
Demand compounds through 2033, outpacing GDP across Product Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Product Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.92BLarge & growingTAM by 2033 at 10.5% CAGR
$2.09BServiceable nowreachable with today’s model
$413MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.62BBear6.8% CAGR
$5.92BBase10.5% CAGR
$7.58BBull13.9% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Tissue Cryo-embedding Machine Market — a $7.23B market by 2033. Plan: grow share from 7.4% to 11.9%.
Market size · 2033$7.23Btotal addressable
Market CAGR6.2%2027–2033
Target share11.9%from 7.4% today
Revenue ambition$860Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.4% | 11.9% | Behind |
| Revenue | $568M | $860M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | At risk |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 31.5% | 39.4% | On track |
| Customer retention | 90.2% | 95.7% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Product Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Product Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $96M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Product Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossBehind
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Tissue Cryo-embedding Machine Market conversation — a $3.57B market you can size, segment and defend in minutes.
Market size · 2033$3.57Btotal opportunity
Growth6.9%CAGR to 2033
Addressable buyers1,064+accounts in scope
Typical ROI4.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Product Type
Goal Grow share in Product Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.9×return on cost, year one
< 3 mopayback period
$88K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Leica BiosystemsThermo Fisher ScientificSakura FinetekMilestone MedicalHisto-Line LaboratoriesBright Instrument Co. Ltd.Matsunami Glass Ind. Ltd.SLEE Medical GmbH+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Tissue Cryo-embedding Machine Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Tissue Cryo-embedding Machine Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Tissue Contact Probe Ablators Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportTissue Clearing Reagent Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportTissue Block Storage Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportTissue Bath System Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportTissue-Based Diagnostics Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportTissue and Organ Transplantation Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportTissue and Organ Repair and Regeneration 3D Printing Products Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportTislelizumab Injection Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportTiropramide HCL Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportTirofiban Hydrochloride Monohydrate Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportTirofiban Hydrochloride Concentrated Solution for Injection Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportTirofiban Hydrochloride API Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.